Clinical trial
Clinical Study of the BioVentrix Revivent TC for the Treatment of Ischemic Cardiomyopathy
NCT02553785 is registered in ClinicalTrials.gov with BioVentrix as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Study of the BioVentrix Revivent TC for the Treatment of Ischemic Cardiomyopathy
- Lead sponsor
- BioVentrix
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- June 30, 2015
- Completion date
- December 31, 2019
- Enrollment
- 89 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.